Margaret E Brousseau Selected Research

Lipids

12/2010	Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
9/2002	New targets for medical treatment of lipid disorders.
7/2002	Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margaret E Brousseau Research Topics

Disease

9	Coronary Disease (Coronary Heart Disease) 12/2010 - 07/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 08/2005
3	Hypercholesterolemia 05/2005 - 01/2004
2	Atherosclerosis 02/2003 - 04/2002
2	Tangier Disease 02/2003 - 02/2003
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2024
1	Hyperlipidemias (Hyperlipidemia) 03/2024
1	Myocardial Infarction 09/2007
1	Dyslipidemias (Dyslipidemia) 09/2007
1	Diabetes Mellitus 07/2006
1	Insulin Resistance 07/2006
1	Obesity 10/2004
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2004
1	Chronic Renal Insufficiency 10/2004
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 02/2003
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 12/2002
1	Hypertriglyceridemia 09/2002

Drug/Important Bio-Agent (IBA)

6	HDL CholesterolIBA 12/2010 - 07/2002
3	oxidized low density lipoproteinIBA 03/2024 - 05/2003
3	LipidsIBA 12/2010 - 07/2002
3	Atorvastatin (Lipitor)FDA Link 05/2005 - 01/2004
3	Lipoproteins (Lipoprotein)IBA 10/2004 - 12/2002
3	CholesterolIBA 05/2003 - 04/2002
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2003 - 04/2002
2	LDL CholesterolIBA 03/2024 - 05/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2005 - 12/2004
2	HDL LipoproteinsIBA 08/2005 - 04/2004
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 10/2004 - 04/2002
2	Cholesterol Ester Transfer ProteinsIBA 07/2002 - 04/2002
1	ALN-PCSIBA 03/2024
1	AntibodiesIBA 01/2022
1	Alanine (L-Alanine)FDA Link 09/2007
1	Codon (Codons)IBA 09/2007
1	Glucose (Dextrose)FDA LinkGeneric 09/2007
1	Threonine (L-Threonine)FDA Link 09/2007
1	Fatty Acid-Binding ProteinsIBA 09/2007
1	Gemfibrozil (Lopid)FDA LinkGeneric 07/2006
1	PPAR alphaIBA 07/2006
1	torcetrapibIBA 05/2005
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2004
1	DeuteriumIBA 10/2004
1	Apolipoprotein B-100 (Apo B 100)IBA 10/2004
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2004
1	ApolipoproteinsIBA 10/2004
1	Leucine (L-Leucine)FDA Link 10/2004
1	Cytochrome P-450 CYP3AIBA 01/2004
1	Apolipoproteins E (ApoE)IBA 12/2002
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2002
1	Lipase (Acid Lipase)FDA Link 04/2002
1	EnzymesIBA 04/2002
1	Scavenger Receptors (Scavenger Receptor)IBA 04/2002

Therapy/Procedure

5	Therapeutics 08/2005 - 05/2003
1	Secondary Prevention 09/2007
1	Aftercare (After-Treatment) 01/2004